or Try an Advanced Search...

    Technical Analysis for ARTL - Artelo Biosciences, Inc.

    Grade Last Price % Change Price Change
    F 1.36 3.02% 0.04
    ARTL closed up 3.02 percent on Thursday, May 16, 2024, on 16 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Up
    Historical ARTL trend table...
    Date Alert Name Type % Chg
    Crossed Above 20 DMA Bullish 0.00%
    Bollinger Band Squeeze Range Contraction 0.00%
    NR7 Range Contraction 0.00%
    NR7-2 Range Contraction 0.00%
    Fell Below 20 DMA Bearish 3.02%
    Bollinger Band Squeeze Range Contraction 3.02%
    NR7 Range Contraction 3.02%
    Gapped Up Strength 3.02%
    Crossed Above 20 DMA Bullish 2.15%
    Bollinger Band Squeeze Range Contraction 2.15%
    Older End-of-Day Signals for ARTL ...

       Recent Intraday Alerts

    Alert Time
    Up 3% about 3 hours ago
    Rose Above 20 DMA about 5 hours ago
    Rose Above 10 DMA about 5 hours ago
    Up 2% about 5 hours ago
    Up 1% about 5 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    ARTL Chart by TradingView
    Basic chart:

    Profile

    Artelo Biosciences, Inc. is a San Diego-based biopharmaceutical company dedicated to the development and commercialization of proprietary therapeutics targeting the endocannabinoid system. Artelo is rapidly advancing a portfolio of broadly applicable product candidates designed to address significant unmet needs in multiple diseases and conditions, including cancer, pain, and inflammation. Led by proven biopharmaceutical executives collaborating with highly respected researchers and technology experts, the company applies leading edge scientific, regulatory, and commercial discipline to develop high-impact therapies.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Disease Pain Pharmacy Medication Inflammation Cannabinoid

    Is ARTL a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 13 Artelo Biosciences GAAP EPS of -$0.78
    May 13 Artelo Biosciences Reports First Quarter 2024 Financial Results and Provides Business Update
    May 10 Artelo Biosciences to Present at the Pharma Partnering Summit 2024 on May 14th
    Apr 23 Artelo Biosciences Announces Publication of Peer-Reviewed Article Highlighting FABP7 as a Promising Novel Target in Cancer Therapy
    Apr 22 Artelo Biosciences CEO to Appear on Benzinga All Access on April 23rd at Approximately 10:50 AM Eastern Time
    Mar 25 Recap: Artelo Biosciences Q4 Earnings
    Mar 25 Artelo Biosciences GAAP EPS of -$3.14 misses by $0.58
    Mar 25 Artelo Biosciences Reports Fiscal 2023 Year-End Financial Results and Provides Business Update
    Mar 12 Artelo Biosciences Selected as a Finalist in Johnson & Johnson’s Innovation Challenge
    Feb 15 Artelo Biosciences to Present at the Winter Wrap-Up MicroCap Rodeo Conference on February 20th
    See more ARTL news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 2.98
    52 Week Low 1.16
    Average Volume 12,648
    200-Day Moving Average 1.50
    50-Day Moving Average 1.43
    20-Day Moving Average 1.33
    10-Day Moving Average 1.33
    Average True Range 0.08
    RSI (14) 49.49
    ADX 26.97
    +DI 9.88
    -DI 16.64
    Chandelier Exit (Long, 3 ATRs) 1.23
    Chandelier Exit (Short, 3 ATRs) 1.48
    Upper Bollinger Bands 1.39
    Lower Bollinger Band 1.28
    Percent B (%b) 0.75
    BandWidth 8.18
    MACD Line -0.03
    MACD Signal Line -0.03
    MACD Histogram 0.0069
    Fundamentals Value
    Market Cap 4.34 Million
    Num Shares 3.19 Million
    EPS -3.33
    Price-to-Earnings (P/E) Ratio -0.41
    Price-to-Sales 0.00
    Price-to-Book 0.32
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.42
    Resistance 3 (R3) 1.41 1.39 1.41
    Resistance 2 (R2) 1.39 1.37 1.39 1.41
    Resistance 1 (R1) 1.37 1.36 1.38 1.38 1.40
    Pivot Point 1.35 1.35 1.35 1.35 1.35
    Support 1 (S1) 1.33 1.33 1.34 1.34 1.32
    Support 2 (S2) 1.31 1.32 1.31 1.31
    Support 3 (S3) 1.29 1.31 1.31
    Support 4 (S4) 1.30